CUSIP: 760273102
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
42,837,925
-
Total 13F shares
-
32,606,123
-
Share change
-
-80,580
-
Total reported value
-
$464,339,399
-
Put/Call ratio
-
0%
-
Price per share
-
$14.24
-
Number of holders
-
61
-
Value change
-
-$15,992,556
-
Number of buys
-
29
-
Number of sells
-
30
Security key
760273102
Report period
Q1 2022
Institutions
61
Top holders
10
Reporting periods
Holder history for CUSIP 760273102
Recent filing periods:
Top shareholders of RPTX - Repare Therapeutics Inc. - Common shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q1 2022
As of 31 Mar 2022,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,606,123 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, FMR LLC, ARK Investment Management LLC, Redmile Group, LLC, Deep Track Capital, LP, CHI Advisors LLC, MPM ASSET MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BIOIMPACT CAPITAL LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2022 vs Q4 2021 Across Filers
| Investor |
Q4 2021 Shares |
Q1 2022 Shares |
Share Diff |
Share Chg % |
Q4 2021 Value $ |
Q1 2022 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.